Firm type · Focus area

Drug Discovery Private Equity Firms

The RaiseHunt database lists 244 Drug Discovery private equity firms: all of them list a portfolio, 2,281 known investments between them and 1,314 people at those firms have a profile here. That is the overlap between 7,421 private equity firms and 1,313 Drug Discovery investment firms. Most list Growth and Series B among the rounds they take part in; the largest concentrations are in New York, London and Boston.

Part of private equity firms and Drug Discovery investment firms.

Strongest in New York, London and Boston

Backing rounds at Growth and Series B

244
Investment firms
244
With a known portfolio
2,281
Known investments
1,314
People with a profile

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

244 Drug Discovery private equity firms

Showing 241-244

Beijing, China
Private equity
AIHealthcare
View fund
Taipei, Taiwan
Private equity
Healthcare
View fund
Research Triangle Park, United States
AcceleratorPrivate equity
Healthcare
View fund
London, United Kingdom
Private equityVenture capital
Healthcare
View fund

Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal